|
G |
Gpc1 |
glypican 1 |
decreases degradation |
ISO |
3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one results in decreased degradation of GPC1 protein |
CTD |
PMID:21642435 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity |
ISO |
Itraconazole results in decreased activity of ABCB11 protein |
CTD |
PMID:20829430 PMID:23956101 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
affects activity decreases activity multiple interactions affects transport |
ISO |
Itraconazole affects the activity of ABCB1 protein Itraconazole results in decreased activity of ABCB1 protein Itraconazole inhibits the reaction [ABCB1 protein affects the transport of Digoxin]; Itraconazole promotes the reaction [ABCB1 gene SNP affects the susceptibility to fexofenadine] ABCB1 protein affects the transport of Itraconazole |
CTD |
PMID:15905803 PMID:15964336 PMID:15969931 PMID:16084853 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Acvr1c |
activin A receptor type 1C |
increases expression |
ISO |
Itraconazole results in increased expression of ACVR1C mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
AHR promotes the reaction [Itraconazole results in increased expression of NQO1 mRNA]; AHR promotes the reaction [Itraconazole results in increased expression of NQO1 protein] |
CTD |
PMID:17923278 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Amdhd1 |
amidohydrolase domain containing 1 |
decreases expression |
ISO |
Itraconazole results in decreased expression of AMDHD1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 7:28,043,923...28,059,156
Ensembl chr 7:28,043,716...28,059,156
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Itraconazole binds to and results in decreased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bicc1 |
BicC family RNA binding protein 1 |
decreases expression |
ISO |
Itraconazole results in decreased expression of BICC1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr20:17,449,639...17,686,775
Ensembl chr20:17,449,560...17,686,776
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] |
CTD |
PMID:23688403 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Cpn2 |
carboxypeptidase N subunit 2 |
decreases expression |
ISO |
Itraconazole results in decreased expression of CPN2 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr11:70,486,054...70,495,937
Ensembl chr11:70,486,057...70,496,472
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
Itraconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 mRNA]; Itraconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 protein] |
CTD |
PMID:24471457 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
Itraconazole results in increased expression of CXCL1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
multiple interactions |
ISO |
Itraconazole binds to and results in decreased activity of CYP11B1 protein |
CTD |
PMID:31982514 |
|
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
Itraconazole binds to and results in decreased activity of CYP11B2 protein |
CTD |
PMID:31982514 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression decreases activity |
ISO |
Dactinomycin inhibits the reaction [Itraconazole results in increased expression of CYP1A1 mRNA]; Itraconazole results in increased expression of and results in increased activity of CYP1A1 protein Itraconazole results in increased expression of CYP1A1 mRNA; Itraconazole results in increased expression of CYP1A1 protein Itraconazole results in decreased activity of CYP1A1 protein |
CTD |
PMID:17283379 PMID:28390928 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
decreases activity |
ISO EXP |
Itraconazole results in decreased activity of CYP24A1 protein |
CTD |
PMID:15328084 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases hydroxylation affects activity decreases activity affects metabolic processing increases metabolic processing decreases expression |
ISO |
Itraconazole binds to and results in decreased activity of CYP3A4 protein CYP3A4 protein results in increased hydroxylation of Itraconazole Itraconazole affects the activity of CYP3A4 protein Itraconazole results in decreased activity of CYP3A4 protein CYP3A4 protein affects the metabolism of Itraconazole CYP3A4 protein results in increased metabolism of Itraconazole Itraconazole results in decreased expression of CYP3A4 mRNA; Itraconazole results in decreased expression of CYP3A4 protein |
CTD |
PMID:15328084 PMID:15383492 PMID:15447735 PMID:15684493 PMID:15784650 PMID:15905803 PMID:15963096 PMID:15964336 PMID:15969931 PMID:16041596 PMID:18218784 PMID:18360572 PMID:28390928 More...
|
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases activity decreases response to substance multiple interactions |
ISO |
Itraconazole results in decreased activity of CYP51A1 protein CYP51A1 gene results in decreased susceptibility to Itraconazole CYP51A1 gene inhibits the reaction [Itraconazole results in decreased chemical synthesis of Ergosterol]; CYP51A1 gene inhibits the reaction [Itraconazole results in decreased metabolism of and results in increased abundance of 14-methylergosta-8,24(28)-dien-3,6-diol]; CYP51A1 gene inhibits the reaction [Itraconazole results in decreased metabolism of and results in increased abundance of Lanosterol] |
CTD |
PMID:16989930 PMID:18694951 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Dclre1c |
DNA cross-link repair 1C |
increases expression |
ISO |
Itraconazole results in increased expression of DCLRE1C mRNA |
CTD |
PMID:31099283 |
|
NCBI chr17:74,775,828...74,810,089
Ensembl chr17:74,776,935...74,809,186
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Itraconazole results in increased expression of DDIT3 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dtna |
dystrobrevin, alpha |
decreases expression |
ISO |
Itraconazole results in decreased expression of DTNA mRNA |
CTD |
PMID:31099283 |
|
NCBI chr18:14,687,193...14,944,232
Ensembl chr18:14,587,852...14,944,261
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
decreases expression |
ISO |
Itraconazole results in decreased expression of ENPP3 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
decreases expression |
ISO |
Itraconazole results in decreased expression of ESCO2 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
|
|
G |
Esrra |
estrogen related receptor, alpha |
decreases expression |
ISO |
Itraconazole results in decreased expression of ESRRA mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
increases expression |
ISO |
Itraconazole results in increased expression of FABP5 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
Itraconazole results in increased expression of FOSL1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
decreases expression |
ISO |
Itraconazole results in decreased expression of GFPT1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
ISO |
Itraconazole results in decreased expression of GJB1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression |
ISO EXP |
Itraconazole analog results in decreased expression of GLI1 mRNA; Itraconazole results in decreased expression of GLI1 mRNA |
CTD |
PMID:21936514 PMID:33905526 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases expression |
ISO |
Itraconazole results in increased expression of GOT1 protein |
CTD |
PMID:31099283 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpr6 |
G protein-coupled receptor 6 |
decreases expression |
ISO |
Itraconazole results in decreased expression of GPR6 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr20:44,489,853...44,492,624
Ensembl chr20:44,489,853...44,492,624
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression |
ISO |
Itraconazole results in increased expression of GPT protein |
CTD |
PMID:31099283 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
Itraconazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] |
CTD |
PMID:23769903 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
decreases expression |
ISO |
Itraconazole results in decreased expression of GULP1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
increases expression |
ISO |
Itraconazole results in increased expression of HMGA2 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
ISO |
Itraconazole results in increased expression of HMGCS1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
decreases expression |
ISO |
Itraconazole results in decreased expression of HMGCS2 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
decreases activity |
ISO |
Itraconazole results in decreased activity of HSD11B2 protein |
CTD |
PMID:28131847 PMID:29385285 PMID:33387577 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
decreases expression |
EXP |
Itraconazole results in decreased expression of IHH mRNA |
CTD |
PMID:33905526 |
|
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
|
|
G |
Il12b |
interleukin 12B |
increases expression |
ISO |
Itraconazole results in increased expression of IL12B mRNA |
CTD |
PMID:31099283 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il4 |
interleukin 4 |
multiple interactions decreases expression decreases secretion |
ISO |
1-Methyl-3-isobutylxanthine inhibits the reaction [Itraconazole results in decreased expression of IL4 mRNA]; 1-Methyl-3-isobutylxanthine inhibits the reaction [Itraconazole results in decreased secretion of IL4 protein]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of 15-deoxy-delta(12,14)-prostaglandin J2]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of Prostaglandin D2]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein]]; Bucladesine inhibits the reaction [Itraconazole results in decreased expression of IL4 mRNA]; Bucladesine inhibits the reaction [Itraconazole results in decreased secretion of IL4 protein]; Colforsin inhibits the reaction [Itraconazole results in decreased expression of IL4 mRNA]; Colforsin inhibits the reaction [Itraconazole results in decreased secretion of IL4 protein]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of 15-deoxy-delta(12,14)-prostaglandin J2]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of Prostaglandin D2]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased degradation of NFKBIA protein]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CXCL8 mRNA]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2]; Itraconazole promotes the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Dinoprostone] |
CTD |
PMID:11886533 PMID:15284827 PMID:23688403 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions decreases secretion decreases expression |
ISO |
1-Methyl-3-isobutylxanthine inhibits the reaction [Itraconazole results in decreased expression of IL5 mRNA]; 1-Methyl-3-isobutylxanthine inhibits the reaction [Itraconazole results in decreased secretion of IL5 protein]; Bucladesine inhibits the reaction [Itraconazole results in decreased expression of IL5 mRNA]; Bucladesine inhibits the reaction [Itraconazole results in decreased secretion of IL5 protein]; Colforsin inhibits the reaction [Itraconazole results in decreased expression of IL5 mRNA]; Colforsin inhibits the reaction [Itraconazole results in decreased secretion of IL5 protein] |
CTD |
PMID:11886533 PMID:15284827 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Madcam1 |
mucosal vascular addressin cell adhesion molecule 1 |
multiple interactions |
ISO |
Itraconazole inhibits the reaction [TNF protein results in increased expression of MADCAM1 protein] |
CTD |
PMID:12388057 |
|
NCBI chr 7:10,036,301...10,039,703
Ensembl chr 7:10,036,301...10,039,703
|
|
G |
Mbd1 |
methyl-CpG binding domain protein 1 |
increases expression |
ISO |
Itraconazole results in increased expression of MBD1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr18:67,869,870...67,884,501
Ensembl chr18:67,869,992...67,886,554
|
|
G |
Myt1 |
myelin transcription factor 1 |
increases expression |
ISO |
Itraconazole results in increased expression of MYT1 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 3:168,890,466...168,950,341
Ensembl chr 3:168,886,089...168,950,341
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
multiple interactions |
ISO |
Itraconazole promotes the reaction [Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein]] |
CTD |
PMID:17998298 |
|
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased degradation of NFKBIA protein] |
CTD |
PMID:23688403 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression |
ISO |
AHR promotes the reaction [Itraconazole results in increased expression of NQO1 mRNA]; AHR promotes the reaction [Itraconazole results in increased expression of NQO1 protein]; Dactinomycin inhibits the reaction [Itraconazole results in increased expression of NQO1 mRNA] Itraconazole results in increased expression of NQO1 mRNA; Itraconazole results in increased expression of NQO1 protein |
CTD |
PMID:17923278 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases expression |
ISO |
Itraconazole promotes the reaction [Rifampin promotes the reaction [NR1I2 protein binds to NCOA1 protein]]; Itraconazole promotes the reaction [Rifampin results in increased expression of NR1I2 mRNA] Itraconazole results in increased expression of NR1I2 mRNA |
CTD |
PMID:17998298 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Oaz3 |
ornithine decarboxylase antizyme 3 |
decreases expression |
ISO |
Itraconazole results in decreased expression of OAZ3 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 2:182,073,212...182,076,147
Ensembl chr 2:182,073,215...182,082,399
|
|
G |
Pnma2 |
PNMA family member 2 |
increases expression |
ISO |
Itraconazole results in increased expression of PNMA2 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr15:41,111,942...41,119,649
Ensembl chr15:41,112,009...41,121,427
|
|
G |
Ptch1 |
patched 1 |
decreases expression |
EXP |
Itraconazole results in decreased expression of PTCH1 mRNA |
CTD |
PMID:33905526 |
|
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
decreases expression |
ISO |
Itraconazole results in decreased expression of RAPGEF4 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rgs16 |
regulator of G-protein signaling 16 |
decreases expression |
ISO |
Itraconazole results in decreased expression of RGS16 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
|
|
G |
Rpp25 |
ribonuclease P and MRP subunit p25 |
increases expression |
ISO |
Itraconazole results in increased expression of RPP25 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 8:57,907,352...57,908,732
Ensembl chr 8:57,907,352...57,908,732
|
|
G |
Sema3e |
semaphorin 3E |
increases expression |
ISO |
Itraconazole results in increased expression of SEMA3E mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 4:20,297,534...20,555,287
Ensembl chr 4:20,299,718...20,555,229
|
|
G |
Slc25a36 |
solute carrier family 25 member 36 |
increases expression |
ISO |
Itraconazole results in increased expression of SLC25A36 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 8:97,659,848...97,693,735
Ensembl chr 8:97,662,127...97,693,703
|
|
G |
Smo |
smoothened, frizzled class receptor |
decreases expression |
EXP |
Itraconazole results in decreased expression of SMO mRNA |
CTD |
PMID:33905526 |
|
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
Itraconazole inhibits the reaction [Biological Products results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:24471457 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stx8 |
syntaxin 8 |
increases expression |
ISO |
Itraconazole results in increased expression of STX8 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr10:52,655,643...52,900,048
Ensembl chr10:52,654,990...52,894,993
|
|
G |
Sycp3 |
synaptonemal complex protein 3 |
increases expression |
ISO |
Itraconazole results in increased expression of SYCP3 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511
|
|
G |
Tbc1d9 |
TBC1 domain family member 9 |
increases expression |
ISO |
Itraconazole results in increased expression of TBC1D9 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr19:24,842,166...24,951,383
Ensembl chr19:24,842,205...24,943,129
|
|
G |
Tmem138 |
transmembrane protein 138 |
decreases expression |
ISO |
Itraconazole results in decreased expression of TMEM138 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 1:207,219,113...207,226,159
|
|
G |
Tmsb4x |
thymosin beta 4, X-linked |
decreases expression |
ISO |
Itraconazole results in decreased expression of TMSB4X mRNA |
CTD |
PMID:31099283 |
|
NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Itraconazole inhibits the reaction [TNF protein results in increased expression of MADCAM1 protein] |
CTD |
PMID:12388057 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tslp |
thymic stromal lymphopoietin |
multiple interactions |
ISO |
4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein]]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein] |
CTD |
PMID:23688403 |
|
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
|
|
G |
Tspan8 |
tetraspanin 8 |
decreases expression |
ISO |
Itraconazole results in decreased expression of TSPAN8 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 7:51,444,946...51,479,360
Ensembl chr 7:51,445,074...51,479,356
|
|
G |
Zfp451 |
zinc finger protein 451 |
increases expression |
ISO |
Itraconazole results in increased expression of ZFP451 mRNA |
CTD |
PMID:31099283 |
|
NCBI chr 9:35,985,441...36,040,991
Ensembl chr 9:35,985,443...36,040,652
|
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression |
ISO |
sonidegib results in decreased expression of GLI1 mRNA |
CTD |
PMID:24973920 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gli2 |
GLI family zinc finger 2 |
decreases expression multiple interactions decreases response to substance |
ISO |
sonidegib results in decreased expression of GLI2 mRNA sonidegib inhibits the reaction [SUFU gene mutant form results in increased expression of GLI2 mRNA] GLI2 protein results in decreased susceptibility to sonidegib |
CTD |
PMID:24973920 |
|
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases phosphorylation |
EXP |
sonidegib results in increased phosphorylation of MTOR protein |
CTD |
PMID:31568847 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
decreases response to substance |
ISO |
MYCN protein results in decreased susceptibility to sonidegib |
CTD |
PMID:24973920 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Smo |
smoothened, frizzled class receptor |
decreases response to substance |
ISO |
SMO protein mutant form results in decreased susceptibility to sonidegib |
CTD |
PMID:24973920 |
|
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Sufu |
SUFU negative regulator of hedgehog signaling |
multiple interactions decreases response to substance |
ISO |
sonidegib inhibits the reaction [SUFU gene mutant form results in increased expression of GLI2 mRNA] SUFU gene mutant form results in decreased susceptibility to sonidegib |
CTD |
PMID:24973920 |
|
NCBI chr 1:245,257,725...245,355,576
Ensembl chr 1:245,257,768...245,355,577
|
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]; HhAntag691 inhibits the reaction [AGT protein results in increased expression of GLI1 protein]; HhAntag691 inhibits the reaction [AGT protein results in increased expression of GLI2 protein]; HhAntag691 inhibits the reaction [AGT protein results in increased expression of SHH protein] |
CTD |
PMID:31181250 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of BCL2 protein] |
CTD |
PMID:22087285 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [nickel monoxide results in decreased expression of BECN1 protein] |
CTD |
PMID:34608745 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp3 |
caspase 3 |
increases cleavage |
ISO |
HhAntag691 results in increased cleavage of CASP3 protein |
CTD |
PMID:22087285 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
HhAntag691 results in decreased expression of CCND1 mRNA |
CTD |
PMID:24973920 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
ISO |
HhAntag691 results in decreased expression of CCND2 mRNA |
CTD |
PMID:24973920 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
HhAntag691 results in decreased expression of CDK6 mRNA |
CTD |
PMID:24973920 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression multiple interactions |
ISO |
HhAntag691 results in increased expression of FAS protein [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of FAS protein] |
CTD |
PMID:22087285 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Gli1 |
GLI family zinc finger 1 |
multiple interactions decreases expression |
ISO |
[GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of BCL2 protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of PDGFRA protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of FAS protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10A protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10B protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the susceptibility to HhAntag691; HhAntag691 inhibits the reaction [AGT protein results in increased expression of GLI1 protein]; HhAntag691 inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] vismodegib decreases Gli1 protein expression in pituitary adenoma cells HhAntag691 results in decreased expression of GLI1 mRNA |
CTD RGD |
PMID:22087285 PMID:24973920 PMID:27585885 PMID:31181250 PMID:31642701 PMID:31519191 More...
|
RGD:150573695 |
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gli2 |
GLI family zinc finger 2 |
multiple interactions increases response to substance decreases expression decreases response to substance |
ISO |
[GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of BCL2 protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of PDGFRA protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of FAS protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10A protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10B protein]; [GLI1 mRNA co-treated with GLI2 mRNA] affects the susceptibility to HhAntag691; HhAntag691 inhibits the reaction [AGT protein results in increased expression of GLI2 protein] GLI2 gene mutant form results in increased susceptibility to HhAntag691 HhAntag691 results in decreased expression of GLI2 mRNA GLI2 gene mutant form promotes the reaction [HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA]]; HhAntag691 inhibits the reaction [SUFU gene mutant form results in increased expression of GLI2 mRNA] GLI2 protein results in decreased susceptibility to HhAntag691 |
CTD |
PMID:22087285 PMID:24973920 PMID:27585885 PMID:31181250 |
|
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Gli3 |
GLI family zinc finger 3 |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [AGT protein results in decreased expression of GLI3 protein] |
CTD |
PMID:31181250 |
|
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Hhip |
Hedgehog-interacting protein |
decreases expression |
ISO |
HhAntag691 results in decreased expression of HHIP mRNA |
CTD |
PMID:24973920 |
|
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [nickel monoxide results in decreased lipidation of and results in decreased cleavage of MAP1LC3B protein] |
CTD |
PMID:34608745 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
decreases response to substance |
ISO |
MYCN protein results in decreased susceptibility to HhAntag691 |
CTD |
PMID:24973920 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Pax6 |
paired box 6 |
increases expression |
ISO |
HhAntag691 results in increased expression of PAX6 mRNA |
CTD |
PMID:27585885 |
|
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
multiple interactions decreases expression |
ISO |
[GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of PDGFRA protein] |
CTD |
PMID:22087285 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
increases expression |
ISO |
vismodegib increases protein kinase A protein expression in pituitary adenoma cells |
RGD |
PMID:31519191 |
RGD:150573695 |
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Ptch1 |
patched 1 |
decreases expression multiple interactions |
ISO |
HhAntag691 results in decreased expression of PTCH1 mRNA GLI2 gene mutant form promotes the reaction [HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA]]; HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA] |
CTD |
PMID:22087285 PMID:24973920 PMID:27585885 |
|
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
|
|
G |
Ptch2 |
patched 2 |
decreases expression |
ISO |
HhAntag691 results in decreased expression of PTCH2 mRNA |
CTD |
PMID:22087285 |
|
NCBI chr 5:130,571,956...130,592,506
Ensembl chr 5:130,572,312...130,592,405
|
|
G |
Shh |
sonic hedgehog signaling molecule |
decreases expression multiple interactions |
ISO |
HhAntag691 results in decreased expression of SHH mRNA GLI2 gene mutant form promotes the reaction [HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA]]; HhAntag691 inhibits the reaction [SHH protein results in increased expression of PTCH1 mRNA] HhAntag691 inhibits the reaction [AGT protein results in increased expression of SHH protein]; HhAntag691 inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] |
CTD |
PMID:27585885 PMID:31181250 PMID:31642701 |
|
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Smo |
smoothened, frizzled class receptor |
decreases expression decreases response to substance |
ISO |
HhAntag691 results in decreased expression of SMO mRNA SMO protein mutant form results in decreased susceptibility to HhAntag691 |
CTD |
PMID:22087285 PMID:24973920 |
|
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO |
HhAntag691 inhibits the reaction [nickel monoxide results in increased expression of SQSTM1 protein] |
CTD |
PMID:34608745 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Sufu |
SUFU negative regulator of hedgehog signaling |
decreases response to substance increases expression multiple interactions |
ISO |
SUFU gene mutant form results in decreased susceptibility to HhAntag691 vismodegib increases SUFU protein expression in pituitary adenoma cells HhAntag691 inhibits the reaction [SUFU gene mutant form results in increased expression of GLI2 mRNA] |
CTD RGD |
PMID:24973920 PMID:31519191 |
RGD:150573695 |
NCBI chr 1:245,257,725...245,355,576
Ensembl chr 1:245,257,768...245,355,577
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
increases expression multiple interactions |
ISO |
HhAntag691 results in increased expression of TNFRSF10A protein [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in increased expression of TNFRSF10A protein] |
CTD |
PMID:22087285 |
|
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|